4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-041850
Chief Executive Officer acquired 2,501 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2022-07-07 | Option exercise | +2,501 | $14.54 | $36,365 | 4,060,135 | D |
| Derivatives | |||||||
| Anzalone Christopher Richard Chief Executive Officer | 2022-07-07 | Option exercise · Stock Option (right to buy Common Stock) | −2,501 | 612,532 | D | ||
Loading xslF345X03/doc4.xml…